Testosterone Plus Finasteride Treatment After Spinal Cord Injury
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether testosterone plus finasteride treatment
will improve musculoskeletal health, neuromuscular function, body composition, and metabolic
health in hypogonadal men who have experienced ambulatory dysfunction subsequent to
incomplete spinal cord injury. The investigators hypothesize that this treatment will improve
bone mineral density, enhance muscle size and muscle function, and improve body composition,
without causing prostate enlargement.
Phase:
Phase 2
Details
Lead Sponsor:
VA Office of Research and Development
Collaborator:
University of Florida
Treatments:
Antineoplastic Agents Antineoplastic Agents, Hormonal Bone Density Conservation Agents Finasteride Methyltestosterone Testosterone Testosterone 17 beta-cypionate Testosterone enanthate Testosterone undecanoate